AI制药经济账受关注
2026-07-24 08:53:12
据界面新闻报道，随着互联网大厂开始重新审视AI投入回报，AI制药的成本与收益核算问题也受到关注。文章称，AI制药成本主要包括基础设施、软件与平台授权、人才团队和数据，其中数据成本最易被低估；在收益端，AI在靶点发现、分子设计和患者招募等临床前环节更容易量化，但在II期、III期临床试验及方案设计等关键环节，受数据可得性和监管不确定性制约，落地仍有限。
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
Garrett Jin BTC多仓浮亏逾1400万Next article：
Solana股票代币月交易量飙升
